Translation Manchester funding schemes

Funded by the Wellcome Trust Translational Partnership Award (TPA), we offer two Translation Manchester funding schemes running annually, and a time-limited scheme in partnership with CARD.

2021 Funding calls now open

Every year Translation Manchester runs two translational funding schemes: Access to Expertise (A2E) and Projects for Translation (P4T).

The overall aim of the schemes is to build better links between science, technology and innovation by removing barriers between disciplines and making it easier for researchers to take the first translational steps and successfully progress along the translational pathway.

Both schemes are open for applications from 5th July 2021. 

Key Dates and Deadlines

  • Funding call opens                                           Monday 5th July 2021
  • Information Session  (watch back)                 Wednesday 14th July 2021
  • Deadline for contacting RSMs                         Monday 26th July 2021 or shortly after*
  • Application deadline                                         Thursday 26th August 2021
  • Notification of outcomes                                  w/c 25th October 2021
  • Projects start                                                       November 2021

*Your RSM might not be able to cost your application if not enough time is allowed before the final application deadline of the 26th of August.

Download and read the frequently asked questions for both schemes below.

Access to Expertise

The Access to Expertise award will enable you to access appropriate expertise to help unblock specific bottlenecks associated with translational research. Projects of 6-9 months in duration will be awarded up to £25,000.

The call for applications will open on 5th July 2021 with a deadline of 26th August 2021.

Please download the application brief and the application form below.

Projects for Translation

The Projects for Translation award will fund studies that move research projects along the translational pathway. Projects of 6-9 months in duration will be awarded up to £55,000.

The call for applications will open on 5th July 2021 with a deadline of 26th August 2021.

Please download the application brief and the application form below.

For more information about these schemes watch the launch event below, for any other queries please contact


Translational Research Call for Early Career Researchers

Between April and November 2021, Translation Manchester is partnering with CARD to fund translational research projects within the Researcher Development Schemes; Research Collaboration Fund and Research Dissemination Fund. If your research project involves translational research, it may be eligible for this joint funding opportunity.

Applications submitted to these two funds that have a translational research focus will be eligible for the ring-fenced budget contribution (details below) by answering the relevant question in the application form. Please visit this page to read more about what qualifies as translational research, examples of what activities can be funded and eligibility criteria.

Research Collaboration Fund

Applicants can apply for costs up to a maximum of £5000 to explore opportunities for future collaborative funding bids, to access external training, to fund proof of principle studies and other similar activities.

Research Dissemination Fund

Applicants can apply for the cost of dissemination activities up to a maximum of £500. We do not fund publication costs or attendance to conferences, but public engagement activities are within remit.


Previous awards

Projects for Translation (P4T)

2020 awards

Alan McWilliam
Remote cardiac monitoring in patients follow lung cancer radiotherapy
9 months P4T support

Claudia Lindner
An Automated Software System for Monitoring Developmental Dysplasia of the Hip in Children
9 months P4T support

Jeremy Derrick
Using novel virus-like particle engineering to generate a second generation COVID-19 vaccine
9 months P4T support

Josef Schlittenlacher
Hearing Health: Personalised hearing-aid fitting using suprathreshold tests
12 months P4T support

Rachel Watson
Systemic sclerosis-related calcinosis: developing safe, effective topical treatments to reduce pain, ulceration and disability (TOPiCAL) project
6 months P4T support

2018 awards

Brian Bigger
Establish manufacturing scale-up of lentiviral transduction of peripheral blood derived CD34+ stem cells at GMP
9 months P4T support

Tony Day & Caroline Milner
Development of Link_TSG6 as a protein biological with disease-modifying and anti-inflammatory properties
9 months P4T support

Mike Bromley
The Aspergillus fumigatus Gene and Non Coding RNA Knockout Library.
6 months P4T support

Ellen Poliakoff
Action Imagery and Observation in Neurorehabilitation for Parkinson’s Disease (ACTION-PD)
6 months P4T support

William Newman
Development and implementation of a point-of-care pharmacogenetic test to avoid antibiotic-related hearing loss in neonates
12 months P4T support

Access to Expertise (A2E)

2020 awards

Adam Reid
ComplexWounds@Manchester – Biobank
12 months access to research nurse

Claudia Lindner
Establishing a data sharing platform between clinicians and researchers for studying children’s hip diseases
8 months access to IT and imaging expertise

James Eales
A non-invasive “liquid biopsy” for chronic kidney disease
6 months access to expertise in single cell sequencing

Matthew Gittins
Improving patient outcomes and experience – translating stroke research expertise to Vestibular Schwannoma
12 month access to biostatics expertise and clinician time

Patrick Hamilton
Antigen specific therapy for Autoimmune Membranous Nephropathy (AMN)
9 months access to technical experimental expertise within a commercial company

Samuel Jones
Identifying the pathway to the clinic for broad spectrum antiviral polymers
6 months access to clinical trial expertise

2019 awards

Silke Brix
Risk stratification and modified immunotherapy to reduce mortality in elderly patients with ANCA-associated glomerulonephritis
4 months access to statistical expertise

Govind Oliver
Technology enhanced care in cardiac arrest
8 months access to software development expertise and clinician time

Paul Bishop
In-silico prediction of potential for immunogenicity of AMD therapeutics
3 months access to in silico evaluation expertise

Anna Woollams
Using clinical imaging to optimise therapy for individuals with aphasia
9 months access to app development and delivery expertise

James Fildes
Developing an arterial leukocyte filter that mimics leukocyte adhesion
6 months access to external peptide synthesis expertise

Jordi Bella
Engineered recombinant collagens for tissue regeneration applications
9 months access to expertise in TPP development

Tony Day
Development of Link-TSG6 as a protein biological with disease-modifying and anti-inflammatory properties
5 months access to bioinformatics expertise

Emma Gowen
Developing a partnership between Autism@Manchester and GMMH NHS autism services
9 months access to clinician and research co-ordinator time

2018 awards

Kathryn Abel
mSootheBox: Developing a Digital Health Intervention for Self Harm Management for Children and Young People
9 months access to augmented reality expertise and funds to establish an expert Research User Group

Jordi Bella
Cost of goods model for the manufacture of engineered recombinant collagens for tissue regeneration applications
6 months access to expertise to develop a cost of goods model.

Jeremy Derrick
Stratification by Immuno-profiling of IgG in Rheumatoid Arthritis and Psoriasis Patients
3 months access to informatics expertise 

Tracy Hussell
Macrophage adaptation in the inflamed lung
12 months access to clinician time for clinical sample collection

Matthias Pierce
‘CAPRI’: Children and Adolescents with PaRental mental Illness: Understanding the ‘who’ and the ‘how’ of targeting interventions
9 months access to an expert health economist

Stephen Richardson
Development of an adipose stem cell-GDF6 regenerative therapy for intervertebral disc degeneration and back pain
9 months access to an expert health economist and expert Research User Group

Mark Travis
Determining a novel pathway that controls TGF-beta activation in the human immune system
3 months access to research nurse and clinician time for clinical sample collection